Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Editas Medicine (EDIT)

$26.85 0.06 (0.22%)

14:47 EST EDIT Stock Quote Delayed 15 Minutes

Volume:

Previous Close $26.91

Market Cap 1.28B

PE Ratio -9.59

EPS -2.8

Volume (Avg. Vol.) 372,670

Day's Range 26.63 - 27.25

52-Week Range 19.29 - 34.37

Dividend & Yield N/A (N/A)

EDIT Stock Predictions, Articles, and Editas Medicine News

From the Web

Intellia up 5% on new data from CRSPR/Cas9 programs

From Seeking Alpha Feb 10, 2020

Intellia Therapeutics (NTLA +4.7%) perks up, albeit on below-average volume, on the heels of its program updates:NTLA-5001 in AML: Data show that the company's approach using CRISPR engineering to dev

12 Healthcare Stocks Moving In Monday's Pre-Market Session

From Benzinga Feb 10, 2020

Gainers • vTv Therapeutics, Inc. (NASDAQ:VTVT) stock increased by 71.9% to $3.61 during Monday's pre-market session. • Mereo BioPharma Group, Inc. (NASDAQ:MREO)...

8 Biotechnology Stocks Moving In Monday's Pre-Market Session

From Benzinga Feb 10, 2020

Gainers • vTv Therapeutics, Inc. (NASDAQ:VTVT) shares rose 71.9% to $3.61 during Monday's pre-market session. • Mereo BioPharma Group, Inc. (NASDAQ:MREO) shares...

Here's Why CRISPR Stocks Fell in January

From The Motley Fool Feb 5, 2020

What's expected to be a busy year for CRISPR stocks started off with a thud, not a bang.

Noteworthy Monday Option Activity: YUMC, BG, EDIT

From Market News Video Jan 27, 2020

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Yum China Holdings Inc (YUMC), where a total of 11,580 contracts have traded so far, representing approximately 1.2 million underlying shares. That amounts to about 55.8% of YUMC's average daily trading volume over the past month of 2.1 million shares..

The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics

From Benzinga Jan 16, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 15) 10X Genomics Inc (NASDAQ...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold